Syk tyrosine kinase is overexpressed in the majority of peripheral T- and NK-cell lymphomas, and represents a potential therapeutic target.

被引：0
|
作者：
Feldman, Andrew L. [1 ]
Sun, David X. [1 ]
Law, Mark E. [1 ]
Novak, Anne J. [2 ]
Attygalle, Ayoma D. [3 ]
Thorland, Erik C. [1 ]
Fink, Stephanie R. [1 ]
Vrana, Julie A. [1 ]
Caron, B. Lynn [1 ]
Morice, William G. [1 ]
Remstein, Ellen D. [1 ]
Grogg, Karen L. [1 ]
Kurtin, Paul J. [1 ]
Macon, William R. [1 ]
Dogan, Ahmet [1 ]
机构：
[1] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Royal Marsden Hosp, London SW3 6JJ, England
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.690.690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
690
引用
收藏
页码：212A / 212A
页数：1
相关论文
共 50 条
  • [1] Spleen Tyrosine Kinase (SYK) Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
    Buchner, Maike
    Fuchs, Simon
    Prinz, Gabriele
    Pfeifer, Dietmar
    Bartholome, Kilian
    Chevalier, Nina
    Vallat, Laurent
    Timmer, Jens
    Gribben, John G.
    Jumaa, Hassan
    Veelken, Hendrik
    Dierks, Christine
    Zirlik, Katja
    BLOOD, 2008, 112 (11) : 203 - 203
  • [2] Extranodal T- and NK-cell lymphomas
    Laurence de Leval
    Andrew L. Feldman
    Stefano Pileri
    Shigeo Nakamura
    Philippe Gaulard
    Virchows Archiv, 2023, 482 : 245 - 264
  • [3] Extranodal T- and NK-cell lymphomas
    de Leval, Laurence
    Feldman, Andrew L.
    Pileri, Stefano
    Nakamura, Shigeo
    Gaulard, Philippe
    VIRCHOWS ARCHIV, 2023, 482 (01) : 245 - 264
  • [4] Clinico-pathological forms of peripheral T- and NK-cell lymphomas
    Foss, HD
    Coupland, SE
    Stein, H
    PATHOLOGE, 2000, 21 (02): : 137 - 146
  • [5] Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
    Feldman, A. L.
    Sun, D. X.
    Law, M. E.
    Novak, A. J.
    Attygalle, A. D.
    Thorland, E. C.
    Fink, S. R.
    Vrana, J. A.
    Caron, B. L.
    Morice, W. G.
    Remstein, E. D.
    Grogg, K. L.
    Kurtin, P. J.
    Macon, W. R.
    Dogan, A.
    LEUKEMIA, 2008, 22 (06) : 1139 - 1143
  • [6] Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
    A L Feldman
    D X Sun
    M E Law
    A J Novak
    A D Attygalle
    E C Thorland
    S R Fink
    J A Vrana
    B L Caron
    W G Morice
    E D Remstein
    K L Grogg
    P J Kurtin
    W R Macon
    A Dogan
    Leukemia, 2008, 22 : 1139 - 1143
  • [7] A retrospective analysis of mature T- and NK-cell lymphomas
    Jia, Junlei
    Wang, Xiaohui
    Song, Zheng
    Meng, Shen
    Fei, Yue
    Yu, Jingwei
    Liu, Xia
    Han, Xue
    Li, Lanfang
    Qiu, Lihua
    Qian, Zhengzi
    Zhou, Shiyong
    Gong, Wenchen
    Meng, Bin
    Ren, Xiubao
    Wang, Xianhuo
    Zhang, Huilai
    CANCER BIOLOGY & MEDICINE, 2024, 21 (03) : 223 - 229
  • [8] Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
    Buchner, Maike
    Fuchs, Simon
    Prinz, Gabriele
    Pfeifer, Dietmar
    Bartholome, Kilian
    Burger, Meike
    Chevalier, Nina
    Vallat, Laurent
    Timmer, Jens
    Gribben, John G.
    Jumaa, Hassan
    Veelken, Hendrik
    Dierks, Christine
    Zirlik, Katja
    CANCER RESEARCH, 2009, 69 (13) : 5424 - 5432
  • [9] Inhibition of the B cell associated tyrosine kinase SYK as a potential therapeutic target in aggressive lymphomas.
    Bertoni, F
    Ridaidi, A
    Sasso, A
    Uccella, S
    Martin, V
    Napoli, S
    Pruneri, G
    Zucca, E
    Capella, C
    Catapano, CV
    Tibiletti, MG
    Cavalli, F
    BLOOD, 2005, 106 (11) : 424A - 424A
  • [10] Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas
    Feldman, Andrew L.
    Laurent, Camille
    Narbaitz, Marina
    Nakamura, Shigeo
    Chan, Wing C.
    de Leval, Laurence
    Gaulard, Philippe
    VIRCHOWS ARCHIV, 2023, 482 (01) : 265 - 279
12345